Free Trial

The Joint Corp. (NASDAQ:JYNT) Sees Significant Drop in Short Interest

Joint logo with Medical background

The Joint Corp. (NASDAQ:JYNT - Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 436,200 shares, a decline of 9.5% from the January 15th total of 481,800 shares. Based on an average trading volume of 46,700 shares, the days-to-cover ratio is currently 9.3 days.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Skylands Capital LLC raised its holdings in Joint by 10.9% in the 4th quarter. Skylands Capital LLC now owns 738,728 shares of the company's stock worth $7,853,000 after purchasing an additional 72,700 shares in the last quarter. Topline Capital Management LLC bought a new position in Joint in the 4th quarter worth $3,458,000. Clayton Partners LLC raised its holdings in Joint by 36.2% in the 4th quarter. Clayton Partners LLC now owns 310,000 shares of the company's stock worth $3,295,000 after purchasing an additional 82,447 shares in the last quarter. Geode Capital Management LLC raised its holdings in Joint by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 293,133 shares of the company's stock worth $3,116,000 after purchasing an additional 1,552 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Joint by 4.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 216,254 shares of the company's stock worth $2,299,000 after purchasing an additional 10,074 shares in the last quarter. 76.88% of the stock is currently owned by institutional investors.

Joint Stock Performance

NASDAQ:JYNT traded down $0.09 during midday trading on Thursday, reaching $11.36. 33,952 shares of the stock traded hands, compared to its average volume of 33,691. The company has a fifty day moving average of $10.87 and a 200 day moving average of $11.21. Joint has a 12 month low of $9.10 and a 12 month high of $17.82. The stock has a market capitalization of $170.17 million, a P/E ratio of -9.96 and a beta of 1.60.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on JYNT. Roth Mkm lowered their price objective on shares of Joint from $16.00 to $15.00 and set a "buy" rating for the company in a report on Friday, November 8th. StockNews.com upgraded shares of Joint from a "hold" rating to a "buy" rating in a report on Friday, November 15th.

View Our Latest Research Report on Joint

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Read More

Should You Invest $1,000 in Joint Right Now?

Before you consider Joint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.

While Joint currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines